21,977 Shares in Danaher Corporation $DHR Acquired by Palisade Capital Management LP

Palisade Capital Management LP bought a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 21,977 shares of the conglomerate’s stock, valued at approximately $15,824,000.

A number of other large investors have also recently added to or reduced their stakes in the business. Main Street Group LTD bought a new position in shares of Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher during the 2nd quarter valued at $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter worth $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher in the 4th quarter worth $27,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on DHR shares. TD Cowen reduced their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Stifel Nicolaus cut their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. DZ Bank initiated coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Guggenheim decreased their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Read Our Latest Stock Report on Danaher

Danaher Price Performance

NYSE DHR opened at $215.78 on Wednesday. The stock has a market capitalization of $151.69 billion, a PE ratio of 38.33, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a 50 day moving average price of $197.17 and a two-hundred day moving average price of $192.36. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the business posted $0.77 earnings per share. The business’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.